The Case for Chemotherapy Alone for Limited-Stage Hodgkin's Lymphoma

Por Connors, Joseph M.
Publicado em 2012

Diffuse large B-cell lymphoma with involvement of the kidney: outcome and risk of central nervous system relapse

Por Villa, Diego, Connors, Joseph M., Sehn, Laurie H., Gascoyne, Randy D., Savage, Kerry J.
Publicado em 2011

Hand-assisted laparoscopic splenectomy versus open splenectomy for massive splenomegaly: 20-year experience at a Canadian centre

Por Swanson, Todd W., Meneghetti, Adam T., Sampath, Sharadh, Connors, Joseph M., Panton, O. Neely M.
Publicado em 2011

Vascularization predicts overall survival and risk of transformation in follicular lymphoma

Por Farinha, Pedro, Kyle, Alastair H., Minchinton, Andrew I., Connors, Joseph M., Karsan, Aly, Gascoyne, Randy D.
Publicado em 2010

Circos: An information aesthetic for comparative genomics

Por Krzywinski, Martin, Schein, Jacqueline, Birol, İnanç, Connors, Joseph, Gascoyne, Randy, Horsman, Doug, Jones, Steven J., Marra, Marco A.
Publicado em 2009

Genomic testing to determine drug response: measuring preferences of the public and patients using Discrete Choice Experiment (DCE)

Por Najafzadeh, Mehdi, Johnston, Karissa M, Peacock, Stuart J, Connors, Joseph M, Marra, Marco A, Lynd, Larry D, Marra, Carlo A
Publicado em 2013

Effect of Place of Residence and Treatment on Survival Outcomes in Patients With Diffuse Large B-Cell Lymphoma in British Columbia

Por Lee, Benny, Goktepe, Ozge, Hay, Kevin, Connors, Joseph M., Sehn, Laurie H., Savage, Kerry J., Shenkier, Tamara, Klasa, Richard, Gerrie, Alina, Villa, Diego
Publicado em 2014

Automated analysis of multidimensional flow cytometry data improves diagnostic accuracy between mantle cell lymphoma and small lymphocytic lymphoma

Por Zare, Habil, Bashashati, Ali, Kridel, Robert, Aghaeepour, Nima, Haffari, Gholamreza, Connors, Joseph M., Gascoyne, Randy D., Gupta, Arvind, Brinkman, Ryan R., Weng, Andrew P.
Publicado em 2012

Maintenance rituximab following induction R-CHOP chemotherapy in patients with composite or discordant, indolent and aggressive, B-cell non-Hodgkin lymphomas

Por Kansara, Roopesh, Connors, Joseph M., Savage, Kerry J., Gerrie, Alina S., Scott, David W., Slack, Graham W., Gascoyne, Randy D., Sehn, Laurie H., Villa, Diego
Publicado no Haematologica (2016)

Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP

Por Shustik, Jesse, Han, Guangming, Farinha, Pedro, Johnson, Nathalie A., Ben Neriah, Susana, Connors, Joseph M., Sehn, Laurie H., Horsman, Douglas E., Gascoyne, Randy D., Steidl, Christian
Publicado em 2010

Genetic Variation in Cell Death Genes and Risk of Non-Hodgkin Lymphoma

Por Schuetz, Johanna M., Daley, Denise, Graham, Jinko, Berry, Brian R., Gallagher, Richard P., Connors, Joseph M., Gascoyne, Randy D., Spinelli, John J., Brooks-Wilson, Angela R.
Publicado em 2012

CD20 mutations involving the rituximab epitope are rare in diffuse large B-cell lymphomas and are not a significant cause of R-CHOP failure

Por Johnson, Nathalie A., Leach, Stephen, Woolcock, Bruce, deLeeuw, Ronald J., Bashashati, Ali, Sehn, Laurie H., Connors, Joseph M., Chhanabhai, Mukesh, Brooks-Wilson, Angela, Gascoyne, Randy D.
Publicado em 2009

Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma

Por Schuetz, Johanna M, MacArthur, Amy C, Leach, Stephen, Lai, Agnes S, Gallagher, Richard P, Connors, Joseph M, Gascoyne, Randy D, Spinelli, John J, Brooks-Wilson, Angela R
Publicado em 2009

Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival

Por Johnson, Nathalie A., Boyle, Merrill, Bashashati, Ali, Leach, Stephen, Brooks-Wilson, Angela, Sehn, Laurie H., Chhanabhai, Mukesh, Brinkman, Ryan R., Connors, Joseph M., Weng, Andrew P., Gascoyne, Randy D.
Publicado em 2009

Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP

Por Malumbres, Raquel, Chen, Jun, Tibshirani, Rob, Johnson, Nathalie A., Sehn, Laurie H., Natkunam, Yaso, Briones, Javier, Advani, Ranjana, Connors, Joseph M., Byrne, Gerald E., Levy, Ronald, Gascoyne, Randy D., Lossos, Izidore S.
Publicado em 2008

Five-year survival and durability results of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma

Por Chen, Robert, Gopal, Ajay K., Smith, Scott E., Ansell, Stephen M., Rosenblatt, Joseph D., Savage, Kerry J., Connors, Joseph M., Engert, Andreas, Larsen, Emily K., Huebner, Dirk, Fong, Abraham, Younes, Anas
Publicado no Blood (2016)

Durable remissions in a pivotal phase 2 study of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma

Por Gopal, Ajay K., Chen, Robert, Smith, Scott E., Ansell, Stephen M., Rosenblatt, Joseph D., Savage, Kerry J., Connors, Joseph M., Engert, Andreas, Larsen, Emily K., Chi, Xuedong, Sievers, Eric L., Younes, Anas
Publicado no Blood (2015)

Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival

Por Johnson, Nathalie A., Savage, Kerry J., Ludkovski, Olga, Ben-Neriah, Susana, Woods, Ryan, Steidl, Christian, Dyer, Martin J. S., Siebert, Reiner, Kuruvilla, John, Klasa, Richard, Connors, Joseph M., Gascoyne, Randy D., Horsman, Douglas E.
Publicado em 2009

Non-Hodgkin Lymphoma Risk and Variants in Genes Controlling Lymphocyte Development

Por Schuetz, Johanna M., Daley, Denise, Leach, Stephen, Conde, Lucia, Berry, Brian R., Gallagher, Richard P., Connors, Joseph M., Gascoyne, Randy D., Bracci, Paige M., Skibola, Christine F., Spinelli, John J., Brooks-Wilson, Angela R
Publicado em 2013

Analysis of FOXO1 mutations in diffuse large B-cell lymphoma

Por Trinh, Diane L., Scott, David W., Morin, Ryan D., Mendez-Lago, Maria, An, Jianghong, Jones, Steven J. M., Mungall, Andrew J., Zhao, Yongjun, Schein, Jacqueline, Steidl, Christian, Connors, Joseph M., Gascoyne, Randy D., Marra, Marco A.
Publicado em 2013